Opinion ID: 1243130
Heading Depth: 1
Heading Rank: 1

Heading: order denying petition for rehearing en banc and amending opinion and amended opinion.order

Text: The panel voted to deny the petition for rehearing and the petition for rehearing en banc. A judge of our court then called for a vote on whether to rehear this case en banc. The en banc call failed because a majority of the nonrecused active judges voted against en banc consideration. Fed. R.App. P. 35. Therefore, the petition for rehearing en banc is denied. Future petitions for panel rehearing and future petitions for rehearing en banc will not be entertained. Furthermore, the Opinion filed on April 21, 2008, is hereby amended as follows: Starting at the top of slip opinion page 4197. 523 F.3d at 940, there are three sentences. Eliminate the first sentence entirely. Move the second sentence so that it follows the third sentence, so that the two sentences will remain at the top of page 4197. Those two sentences will now read as follows: We do not think that the FDA requires an ingredient list so that manufacturers can mislead consumers and then rely on the ingredient list to correct those misinterpretations and provide a shield for liability for the deception. Instead, reasonable consumers expect that the ingredient list contains more detailed information about the product that confirms other representations on the packaging.